Summary:
This is a randomized study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of RO7034067 in healthy Japanese participants.
Qualified Participants Must:
• Be healthy
•
Be between 18 and 60 years of age
Qualified Participants May Receive:
May recieve compensation of $1,850 or more depending on qualifications